Q3 2017

Filed Nov 13, 2017 · 10-Q · 44 days after period end · 0001437749-17-019116

Q3 2017 · 10-Q

Revenue

$0.00

— vs Q3 2016

Net Income

-$454.57K

N/M vs Q3 2016

EPS Diluted

-$0.04

N/M vs Q3 2016

Operating Income-$527,032N/M

Operating Cash Flow

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2011
Revenue	$0.00	$0.00	$0.00	$12.33M
Net Income	-$454.57K	-$455.48K	-$439.48K	-$4.52M
EPS Diluted	-$0.04	-$0.06	-$0.07	-$0.72

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR